SCHEMBL23901259

SCHEMBL23901259

CC(=O)NCCCC(=O)N(CCC(=O)O)CCC(=O)O

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 1/20 0.58
▸ KDM4E B2RXH2 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ FOLH1 Q04609 1/20 0.43
▸ PAOX Q6QHF9 3/20 0.41
▸ KDM4A O75164 9/20 0.40
▸ KDM4C Q9H3R0 9/20 0.40
▸ MTNR1A P48039 1/20 0.39
▸ MTNR1B P49286 1/20 0.39
▸ KDM5A P29375 1/20 0.39
▸ KDM7A Q6ZMT4 1/20 0.39
▸ PHF8 Q9UPP1 1/20 0.39
▸ KDM2A Q9Y2K7 1/20 0.39
▸ PRMT1 Q99873 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23894071 0.82 MEN1 (0.53) KDM4EKDM4CKDM5A
SCHEMBL285421 0.82 ADRA1A (0.83) ADRA1AKDM4EMAPK1HIF1AFOLH1
Hydrochloric Acid SCHEMBL11026786 0.80 ADRA1A (0.79) ADRA1AKDM4EMAPK1HIF1AFOLH1
SCHEMBL23879339 0.79 PRMT1 (0.36) ADRA1AMAPK1KDM4AKDM4CKDM5A
Phosphoric Acid SCHEMBL8514542 0.79 ADRA1A (0.70) ADRA1AKDM4EMAPK1HIF1AFOLH1
SCHEMBL20159780 0.77 ZDHHC20 (0.46) ADRA1AKDM4EMAPK1KDM4AKDM4C
SCHEMBL406942 0.76 KDM4E (0.56) ADRA1AKDM4EMAPK1HIF1AFOLH1
SCHEMBL1331412 0.76 ADRA1A (0.95) ADRA1AKDM4EMAPK1HIF1AFOLH1
SCHEMBL27941457 0.75 KDM4E (0.67) ADRA1AKDM4EMAPK1HIF1AFOLH1
SCHEMBL8068893 0.75 AKR1B1 (0.60) KDM4CKDM5APHF8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210308277-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2021-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210308277-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS CD2BP2, DCLRE1A, EPCAM ADRA1A 4644/4885KDM4E 3062/4885MAPK1 4173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback